Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
Oregon Health & Science University · Oregon Clinic · +19 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
360
total citations
- FWCI
- 51.48
- Percentile
- 100%
- References
- 91
Citations per year
Authors
94Topics & keywords
Topics
Keywords
- Myeloid leukemia
- Concordance
- Drug response
- Transcriptome
- Drug
- Cohort
- Myeloid
- Oncology
No related works found for this paper.
Funding
- HHHoward Hughes Medical Institute
- ACAmerican Cancer SocietyAward: RSG-17-187-01-LIB
- VFV Foundation for Cancer ResearchAwards: F30CA239335, RSG-19-184-01 \u2013 LIB
- ASAmerican Society of HematologyAward: K08 CA245224
- BSBristol-Myers Squibb
- PPfizer
- AAstraZeneca
- NNovartis
- LALeukemia and Lymphoma Society
- GSGilead Sciences
- AAbbVie
- OHOregon Health and Science University
- UOUniversity of UtahAward: 2400-13
- GAGabrielle's Angel Foundation for Cancer Research
- MFMark Foundation For Cancer Research
- APAgios Pharmaceuticals
- IIncyte
- SFSilver Family Foundation
- ITIterion Therapeutics
- OMOtago Medical Research Foundation
- SServier
- NINational Institutes of HealthAward: P30CA042014
- NHNational Heart, Lung, and Blood InstituteAward: R01HL155426
- NCNational Cancer InstituteAwards: R01CA245002, R01 CA247943, U01CA214116, R01CA214428, R01CA262758, U01CA217862, R01CA229875, U54CA224019, RSG-19-184-01 \u2013 LIB, R00 5K99CA237630, F30CA239335, RSG-19-184-01 – LIB
- NCNational Center for Advancing Translational SciencesAward: UL1TR002369